3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Recruiting
3
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Genitourinary
3
Gastrointestinal
3
Classical hematology
3
Other hematologic neoplasm
2
Myeloid
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
57
Anemia, Refractory, with Excess of Blasts
48
Myelodysplastic Syndromes
44
Venous Thromboembolism
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Anemia, Aplastic
26
Myeloproliferative Disorders
25
Lymphoma, Non-Hodgkin
23
Neoplasms
22
Multiple Myeloma
21
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
20
Anemia
20
Hodgkin Disease
19
Thrombocytopenia
18
Primary Myelofibrosis
18
Leukemia, Myelomonocytic, Chronic
18
Leukemia, Lymphocytic, Chronic, B-Cell
18
Leukemia
18
Hematologic Neoplasms
17
Lymphoma
15
Anemia, Sickle Cell
13
Lymphoma, Follicular
11
Fanconi Anemia
11
Cytopenia
11
Venous Thrombosis
10
Febrile Neutropenia
10
Bone Marrow Failure Disorders
10
Pulmonary Embolism
9
Leukemia, Biphenotypic, Acute
9
Polycythemia Vera
8
Interventions
N(4)-oleylcytosine arabinoside
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Hemorrhage
×
Classical hematology
×
1 year
×
Clear all
NCT07410117
2026-05-27
ROXI-CAT-I
Regeneron Pharmaceuticals
Phase 3
Recruiting
1,120 enrolled
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled
NCT06805097
2025-07-09
ECLAT
Centre Hospitalier Universitaire de Besancon
Recruiting
343 enrolled